#151260

Anti-HIF1A [ESEE122]

Cat. #151260

Anti-HIF1A [ESEE122]

Cat. #: 151260

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Hypoxia-inducible factor 1, alpha subunit (HIF1A)

Class: Monoclonal

Application: ELISA ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Helen Turley

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-HIF1A [ESEE122]
  • Clone: ESEE122
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; WB
  • Description: Induction of the Hif regulated genes, as a consequence of the microenvironment or genetic changes, is known to have an important role in the growth of experimental tumours. HIF1A has been observed in varying subsets of tumour cells from various solid tumours.
  • Immunogen: GST-human HIF-1A amino acids 329-530 fusion protein
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1
  • Recommended controls: Hypoxic cell pellets.

Target Details

  • Target: Hypoxia-inducible factor 1, alpha subunit (HIF1A)
  • Tissue cell line specificity: Hypoxic cell pellets.
  • Target background: Induction of the Hif regulated genes, as a consequence of the microenvironment or genetic changes, is known to have an important role in the growth of experimental tumours. HIF1A has been observed in varying subsets of tumour cells from various solid tumours.

Applications

  • Application: ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Giatromanolaki et al. 2003. J Pathol. 200(2):222-8. PMID: 12754744.
  • DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
  • Hui et al. 2002. Clin Cancer Res. 8(8):2595-604. PMID: 12171890.
  • Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
  • Beasley et al. 2002. Cancer Res. 62(9):2493-7. PMID: 11980639.
  • Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
  • Talks et al. 2000. Am J Pathol. 157(2):411-21. PMID: 10934146.
  • The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.
  • Wiesener et al. 1998. Blood. 92(7):2260-8. PMID: 9746763.
  • Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.